The Role of Osteocalcin in Human Glucose Metabolism: Marker or Mediator?

Overview

Journal Nat Rev Endocrinol

Specialty Endocrinology

Date 2012 Nov 14

PMID 23147574

Citations 105

Authors

Sarah L Booth

Amanda Centi

Steven R Smith

Caren Gundberg

Affiliations

Soon will be listed here.

Abstract

Increasing evidence supports an association between the skeleton and energy metabolism. These interactions are mediated by a variety of hormones, cytokines and nutrients. Here, the evidence for a role of osteocalcin in the regulation of glucose metabolism in humans is reviewed. Osteocalcin is a bone matrix protein that regulates hydroxyapatite size and shape through its vitamin-K-dependent, γ-carboxylated form. The concentration of osteocalcin in the circulation is a measure of bone formation. The undercarboxylated form of osteocalcin is active in glucose metabolism in mice. Total serum osteocalcin concentrations in humans are inversely associated with measures of glucose metabolism; however, human data are inconclusive with regard to the role of uncarboxylated osteocalcin in glucose metabolism because most studies do not account for the influence of vitamin K on the proportion of undercarboxylated osteocalcin or differentiate between the total and uncarboxylated forms of osteocalcin. Furthermore, most human studies do not concomitantly measure other bone turnover markers to isolate the role of osteocalcin as a measure of bone formation from its effect on glucose metabolism. Carefully designed studies are required to define the role of osteocalcin and its carboxylated or undercarboxylated forms in the regulation of glucose metabolism in humans.

Citing Articles

Development and validation of a novel prediction model for osteoporosis : from serotonin to fat-soluble vitamins.

Wang J, Shan L, Hang J, Li H, Meng Y, Cao W Bone Joint Res. 2025; 14(2):111-123.

PMID: 39963851 PMC: 11833741. DOI: 10.1302/2046-3758.142.BJR-2023-0409.R2.

Effects of Exercises of Different Intensities on Bone Microstructure and Cardiovascular Risk Factors in Ovariectomized Mice.

Wang X, Kang Y, Yao J, Gao X, Feng Z, Song Y Int J Mol Sci. 2025; 26(3).

PMID: 39940771 PMC: 11817207. DOI: 10.3390/ijms26031005.

A trend of osteocalcin in diabetes mellitus research: bibliometric and visualization analysis.

Liu Z, Mao Y, Yang K, Wang S, Zou F Front Endocrinol (Lausanne). 2025; 15:1475214.

PMID: 39872315 PMC: 11769813. DOI: 10.3389/fendo.2024.1475214.

Matrix first, minerals later: fine-tuned dietary phosphate increases bone formation in zebrafish.

Cotti S, Di Biagio C, Huysseune A, Koppe W, Forlino A, Witten P JBMR Plus. 2024; 8(8):ziae081.

PMID: 39045128 PMC: 11264301. DOI: 10.1093/jbmrpl/ziae081.

Plasma undercarboxylated osteocalcin dynamics with glycemic stress reflects insulin sensitivity and beta-cell function in humans with and without T2DM.

Fuller K, Bohne E, Mey J, Blackburn B, Miranda V, Varady K Metabol Open. 2023; 20:100264.

PMID: 38115864 PMC: 10728569. DOI: 10.1016/j.metop.2023.100264.

References

Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M . A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol. 2007; 9(11):1273-85. DOI: 10.1038/ncb1647. View

Wellendorph P, Brauner-Osborne H . Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene. 2004; 335:37-46. DOI: 10.1016/j.gene.2004.03.003. View

Stenflo J, Fernlund P, Egan W, Roepstorff P . Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci U S A. 1974; 71(7):2730-3. PMC: 388542. DOI: 10.1073/pnas.71.7.2730. View

Desbois C, Hogue D, Karsenty G . The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem. 1994; 269(2):1183-90. View

Mega J . A new era for anticoagulation in atrial fibrillation. N Engl J Med. 2011; 365(11):1052-4. DOI: 10.1056/NEJMe1109748. View

Brown J, Delmas P, Arlot M, Meunier P . Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1987; 64(5):954-9. DOI: 10.1210/jcem-64-5-954. View

Knapen M, Schurgers L, Shearer M, Newman P, Theuwissen E, Vermeer C . Association of vitamin K status with adiponectin and body composition in healthy subjects: uncarboxylated osteocalcin is not associated with fat mass and body weight. Br J Nutr. 2011; 108(6):1017-24. DOI: 10.1017/S000711451100626X. View

Pollock N, Bernard P, Gower B, Gundberg C, Wenger K, Misra S . Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function. J Clin Endocrinol Metab. 2011; 96(7):E1092-9. PMC: 3135188. DOI: 10.1210/jc.2010-2731. View

Bonds D, Larson J, Schwartz A, Strotmeyer E, Robbins J, Rodriguez B . Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab. 2006; 91(9):3404-10. DOI: 10.1210/jc.2006-0614. View

10.

Gluck O, Maricic M . Skeletal and nonskeletal effects of raloxifene. Curr Osteoporos Rep. 2005; 1(3):123-8. DOI: 10.1007/s11914-996-0007-4. View

11.

Gundberg C, Nieman S, Abrams S, Rosen H . Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab. 1998; 83(9):3258-66. DOI: 10.1210/jcem.83.9.5126. View

12.

Iglesias P, Arrieta F, Pinera M, Botella-Carretero J, Balsa J, Zamarron I . Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance. Clin Endocrinol (Oxf). 2011; 75(2):184-8. DOI: 10.1111/j.1365-2265.2011.04035.x. View

13.

Misra M, Miller K, Cord J, Prabhakaran R, Herzog D, Goldstein M . Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab. 2007; 92(6):2046-52. DOI: 10.1210/jc.2006-2855. View

14.

Booth S, Tucker K, McKeown N, Davidson K, Dallal G, Sadowski J . Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J Nutr. 1997; 127(4):587-92. DOI: 10.1093/jn/127.4.587. View

15.

Pittas A, Harris S, Eliades M, Stark P, Dawson-Hughes B . Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2008; 94(3):827-32. PMC: 2681283. DOI: 10.1210/jc.2008-1422. View

16.

Karsenty G, Ferron M . The contribution of bone to whole-organism physiology. Nature. 2012; 481(7381):314-20. PMC: 9047059. DOI: 10.1038/nature10763. View

17.

Kumm J, Ivaska K, Rohtla K, Vaananen K, Tamm A . Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy. Scand J Clin Lab Invest. 2008; 68(6):459-63. DOI: 10.1080/00365510701832237. View

18.

Bullo M, Moreno-Navarrete J, Fernandez-Real J, Salas-Salvado J . Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk. Am J Clin Nutr. 2011; 95(1):249-55. DOI: 10.3945/ajcn.111.016642. View

19.

Cheung A, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J . Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med. 2008; 5(10):e196. PMC: 2566998. DOI: 10.1371/journal.pmed.0050196. View

20.

Owen T, Aronow M, Shalhoub V, Barone L, Wilming L, Tassinari M . Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 1990; 143(3):420-30. DOI: 10.1002/jcp.1041430304. View